The Week in Review: July 14 – July 21, 2017

Friday, July 21, 2017 News Recap 1) Vosevi Approved in US – Under Review in Canada Vosevi has just been approved in the USA to treat adults with chronic HCV genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis. Vosevi is a fixed-dose, combination tablet containing sofosbuvir, velpatasvir and a new drug, voxilaprevir. Vosevi is the first treatment approved for patients who have been previously treated with DAAs and failed treatment....

Hepatitis C outbreak spurs closer monitoring of Utah health professionals

The hepatitis C outbreak at two Northern Utah hospitals, attributed to a nurse accused of diverting drugs and infecting at least 7 patients, has spurred the state to increase monitoring of health care professionals. The Utah Department of Health has begun working more closely with licensing authorities “to understand when a provider is potentially exposing patients to blood-borne pathogens due to risky behaviors,” said Dr. Angela Dunn, deputy state epidem

Utah Health Department investigation finds 16 cases of hepatitis C

Sixteen infected people have been connected to a hepatitis C outbreak associated with a nurse employed at two northern Utah hospitals, the Utah Department of Health said Monday. Fifteen of the cases were from patients of McKay-Dee Hospital in Ogden, and one case was from Davis Hospital and Medical Center in Layton, according to a press release. The genotype associated with the outbreak was identified as 2b, and the health department focused its investiga